Want to see SE:ORGC full AI Analyst Report?
Top Page
OrganoClick AB
(ORGC)
Select Model
Select Model
Rating:45Neutral
Price Target:
kr0.41
▼(-77.13% Downside)
Action:Reiterated
Date:07/22/26
The score is held down primarily by weak financial performance: declining revenue, large ongoing losses, negative free cash flow, and a highly leveraged balance sheet with a thin equity cushion. Technicals provide only modest support from a short-term rebound above the 20D/50D averages, but the longer-term downtrend and negative MACD limit confidence. Valuation is difficult to justify on earnings given the negative P/E and no dividend yield data.
Positive Factors
Proprietary bio-based chemistry
OrganoClick’s proprietary bio-based chemistry represents a durable competitive advantage in an industry shifting toward sustainability. Ownership of specialized formulations supports differentiation, protects margin potential when adopted, and enables expansion into multiple industrial applications over the medium term.
Negative Factors
Very high financial leverage
Extremely high leverage materially increases refinancing, interest-rate, and solvency risk. With a thin equity cushion, operational setbacks or slower adoption could force dilutive financing or restructuring, constraining long-term strategic flexibility and investments.
Read all positive and negative factors
Positive Factors
Negative Factors
Proprietary bio-based chemistry
OrganoClick’s proprietary bio-based chemistry represents a durable competitive advantage in an industry shifting toward sustainability. Ownership of specialized formulations supports differentiation, protects margin potential when adopted, and enables expansion into multiple industrial applications over the medium term.
Read all positive factors
OrganoClick AB (ORGC) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr70.72M
Dividend YieldN/A
Average Volume (3M)87.89K
Price to Earnings (P/E)―
Beta (1Y)0.59
Revenue Growth-21.95%
EPS Growth-28.77%
CountrySE
Employees39
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)-0.30
Shares Outstanding183,219,120
10 Day Avg. Volume18,569
30 Day Avg. Volume87,893
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)11.75
Price to Sales (P/S)1.68
P/FCF Ratio-16.96
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.13
Revenue Forecast (FY)kr113.00M
OrganoClick AB Business Overview & Revenue Model
Company Description
OrganoClick AB (publ), a technology firm based in Täby, Sweden, was established in 2006. The company specializes in the development, production, and sale of innovative fiber-based materials and chemicals for applications spanning wood treatment, t...
How the Company Makes Money
OrganoClick makes money primarily by selling products and chemical solutions based on its proprietary bio-based chemistry to industrial and consumer-facing markets. Key revenue streams include: (1) Sales of bio-based chemical products to industria...
OrganoClick AB Financial Statement Overview
Summary
Income Statement
22
Negative
Balance Sheet
18
Very Negative
Cash Flow
28
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 90.28M | 106.19M | 127.23M | 145.87M | 115.05M | 110.06M |
| Gross Profit | 14.11M | 14.86M | 31.84M | 35.39M | 12.94M | 18.51M |
| EBITDA | -9.27M | -12.80M | 5.71M | 5.95M | -21.19M | -12.92M |
| Net Income | -32.19M | -36.37M | -17.97M | -15.77M | -41.62M | -31.03M |
Balance Sheet | ||||||
| Total Assets | 136.75M | 135.22M | 126.98M | 150.75M | 162.86M | 188.39M |
| Cash, Cash Equivalents and Short-Term Investments | 480.00K | 2.68M | 538.00K | 10.74M | 15.20M | 34.25M |
| Total Debt | 78.56M | 77.78M | 51.67M | 62.39M | 61.68M | 53.54M |
| Total Liabilities | 121.59M | 114.81M | 89.15M | 97.34M | 95.30M | 80.66M |
| Stockholders Equity | 10.53M | 15.18M | 28.98M | 44.58M | 58.78M | 100.33M |
Cash Flow | ||||||
| Free Cash Flow | -7.35M | -10.51M | -5.51M | -8.08M | -35.35M | -52.34M |
| Operating Cash Flow | -4.03M | -8.29M | 3.60M | 533.00K | -21.22M | -37.69M |
| Investing Cash Flow | -9.91M | -10.99M | -9.11M | -8.61M | -7.45M | -14.65M |
| Financing Cash Flow | 12.08M | 21.42M | -4.69M | 3.60M | 9.63M | 54.56M |
OrganoClick AB Technical Analysis
Negative
1.78
Price Trends
0.43
Negative
0.59
Negative
1.13
Negative
Market Momentum
-0.01
Positive
43.35
Neutral
34.91
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:ORGC, the sentiment is Negative. The current price of 1.78 is above the 20-day moving average (MA) of 0.45, above the 50-day MA of 0.43, and above the 200-day MA of 1.13, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 43.35 is Neutral, neither overbought nor oversold. The STOCH value of 34.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SE:ORGC.
OrganoClick AB Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
54 Neutral | kr347.45M | -18.30 | -8.17% | ― | -1.90% | -13.63% | |
54 Neutral | kr153.41M | 52.24 | 1.04% | 2.89% | -14.23% | 84.80% | |
47 Neutral | kr55.57M | -4.23 | ― | ― | ― | ― | |
46 Neutral | kr305.14M | -6.14 | ― | ― | -56.20% | -50.16% | |
45 Neutral | kr70.72M | -1.17 | -166.81% | ― | -21.95% | -28.77% | |
43 Neutral | kr32.67M | -0.66 | -82.08% | 0.00% | -12.33% | 62.52% |
* Basic Materials Sector Average
SE:ORGC
OrganoClick AB
0.39
-1.47
-79.19%
SE:NEXAM
Nexam Chemical Holding AB
3.39
-0.50
-12.83%
SE:AERO
Svenska Aerogel Holding AB
0.66
-1.31
-66.55%
SE:POLYG
Polygiene AB
4.20
-5.30
-55.81%
SE:IMPC
Impact Coatings AB
2.90
-1.16
-28.50%
SE:XPC
XP Chemistries AB
0.18
-0.11
-38.97%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.